Events

Program Overview Columbia University Irving Medical Center invites you to join the leading educators from Columbia University, addressing Transthyretin cardiac amyloidosis (ATTR-CA), which is an underdiagnosed infiltrative cardiomyopathy resulting from the deposition of misfolded transthyretin proteins in the heart. Early detection and a multidisciplinary approach are essential for effective management. Video Access All registrants will be sent access to view live lectures during the program and access to view the video recordings post-program. Learning Objectives Clinical presentation, diagnostic methods and risk stratification of patients with newly diagnosed ATTR-CA. Management of patients with newly diagnosed systemic ATTR. Management of various organ involvement. Discuss and develop consensus in guidelines for managing relapsed and refractory cases, including the role of salvage therapies and experimental approaches. Joint Accreditation Statement In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Professions in scope for this activity are listed below. Amedco Joint Accreditation #4008163.   Physicians Amedco LLC designates this live virtual activity for a maximum of 5.00 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   Nurse Practitioners The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Physician Assistants The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits are acceptable for continuing medical education requirements for recertification for PAs. Amedco LLC designates this live activity for a maximum of 5.00 AMA PRA Category 1 Credits. PAs should claim only the credit commensurate with the extent of their participation in the activity.

The Herbert and Florence Irving Institute for Cancer Dynamics will continue its seminar series on the topic of mathematical sciences underpinning cancer research. The monthly seminars take place on the second Wednesday of the month, 2:00-3:00 PM EST. The presentations are open to the Columbia community (in person and online) and to researchers outside Columbia (via Zoom). On Wednesday, November 12th (2:00 PM ET), IICD welcomes Dr. Ken Chen from The University of Texas MD Anderson Cancer Center. Seminar hosted by Dr. Khanh Dinh. The seminar will take place in person in Schermerhorn Hall 603 (Morningside Heights campus). If you wish to attend the seminar remotely, please register using the following link: https://columbiauniversity.zoom.us/meeting/register/MJQS81yBS-KWSoJ-fb2E1g Title: TBA Abstract: TBA Bio: Dr. Ken Chen is currently a tenured professor of Bioinformatics and Computational Biology at MD Anderson Cancer Center in Houston, Texas. He is a fellow of the American Institute of Medical and Biological Engineering (AIMBE) and a fellow of the Asia-Pacific Artificial Intelligence Association (AAIA). Having a background in machine learning, statistical signal processing, bioinformatics, and genomics, his primary interest is to develop computational tools to analyze and interpret human genomics and clinical data towards the realization of genomic medicine. Dr. Chen has designed, developed, and co-developed a set of computational tools such as BreakDancer, novoBreak, monoVar, SiFit, TransVar, BreakTrans, BreakFusion, TIGRA, CREST, PolyScan, SomaticSniper, and VarScan, which have been widely applied to characterize individual and population genomics in various large-scale sequencing projects such as those in The Cancer Genome Atlas (TCGA), the 1000 Genomes Project and Human Cell Atlas. He is particularly interested in comprehensively and accurately constructing the genomes and the transcriptomes of various cancer and immune cell populations with a focus on structural variants, towards understanding the heterogeneity and the evolution of cancer and tumor microenvironment as a consequence of genetics and  treatment. He is also interested in correlating genomics with diseases towards identifying biomarkers that are useful for personalized diagnosis and prognosis. If you would like to meet one-on-one (possibly via Zoom) or attend the lunch or dinner with the speaker, please contact the event organizer.

Speaker: Leonard I. Zon, MD, Boston Childen's Hospital Hosted by Stavroula Kousteni, PhD, Professor, Department of Physiology & Cellular Biophysics; Director, Evans MDS Center at Columbia This event is jointly sponsored by the Herbert Irving Comprehensive Cancer Center's (HICCC) Edward P. Evans Center for Myelodysplastic Syndromes (MDS) and the Columbia Stem Cell Initiative (CSCI) at Columbia University. 

Title TBD Speaker TBD     Lecture 12:00-1:00 pm Join via Zoom: https://forms.gle/1mBQvy5iUbBJ6kcRA